CN106619717A - Production method of deproteinized calf blood extractive intermediates - Google Patents

Production method of deproteinized calf blood extractive intermediates Download PDF

Info

Publication number
CN106619717A
CN106619717A CN201611176125.5A CN201611176125A CN106619717A CN 106619717 A CN106619717 A CN 106619717A CN 201611176125 A CN201611176125 A CN 201611176125A CN 106619717 A CN106619717 A CN 106619717A
Authority
CN
China
Prior art keywords
blood
production method
calf
calf blood
removed extraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611176125.5A
Other languages
Chinese (zh)
Inventor
许立民
陆晨
欧小强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Tianhang Biotechnology Co Ltd
Original Assignee
Zhejiang Tianhang Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Tianhang Biotechnology Co Ltd filed Critical Zhejiang Tianhang Biotechnology Co Ltd
Priority to CN201611176125.5A priority Critical patent/CN106619717A/en
Publication of CN106619717A publication Critical patent/CN106619717A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
  • Feed For Specific Animals (AREA)

Abstract

The invention provides a production method of deproteinized calf blood extractive intermediates. The production method comprises the steps of isolating, grinding, denaturing, ultrafiltration, aseptic filling and the like. The raw blood collected herein is calf blood collected with 14 hours after birth of a calf, and has higher content of active ingredients than calf blood of the ordinary part; the production method has few steps and short production process, the purity of deproteinized calf blood extractive intermediates is fully guaranteed, and utilization value of calf blood is increased.

Description

A kind of production method of calf blood protein-removed extraction intermediate
Technical field:
The present invention relates to belong to deprotein extract production field, a kind of production of calf blood protein-removed extraction intermediate Method.
Background technology:
At present existing calf blood protein-removed extraction intermediate mostly gathers the calf from after being born within 6 months, real Border situation is that the ox age section ox source is less, thereby increases and it is possible to participates in the big ox blood in part, therefore affects the activity of the product.
And the production method of existing calf blood protein-removed extraction intermediate is all chemical leaching test, such as China substantially Patent of invention:A kind of deproteinized calf blood extractive injection and its preparation side disclosed in CN200910246717.3 Method, its method adds sodium citrate for little ox blood, and the stirring that adds water heats up, and is cooled to -10~0 DEG C under stirring rapidly, is centrifuged, supernatant PH value is adjusted, pepsin enzymolysis is added, is filtered, adjust pH value, add subtilopeptidase A enzymolysis, filtered;Filtrate adds Ethanol water is stirred, and centrifugation, supernatant crosses activated-charcoal column, merges eluent and percolation liquid, is concentrated into without ethanol flavor, concentrate Xylitol and epsilon-polylysine are added, is diluted with water, ultrafiltration;Ultrafiltrate dispenses filling rear ultraviolet sterilization, and packaging is obtained final product.It is such Method is not only complicated, and needs to add substantial amounts of chemical substance, so as to destroy the pure property of calf blood protein-removed extraction.
The content of the invention:
For the above-mentioned deficiency of prior art, the technical problem to be solved is to provide a kind of deproteinized calf blood The production method of extract intermediate, solves prior art complexity, and needs to add substantial amounts of chemical substance, so as to destroy The problem of the pure property of calf blood protein-removed extraction.
The technology solution of the present invention is as follows:
A kind of production method of calf blood protein-removed extraction intermediate, including:
A, take blood:Whole bovine blood is gathered under cleaning ambient;
B, separation:Whole bovine blood constant temperature is placed after serum and clot natural separation into whole blood, centrifugation removes serum After obtain clot, and clot cryogenic freezing is preserved;
C, mill:The clot of freezing is thawed to normal temperature and adds purified water, mixed liquor is obtained after being well mixed;
D, denaturation:Mixed liquor is added into the denaturation that heats up in retort, less than 50 DEG C are cooled to after denaturation carries out being centrifuged again To centrifugate, by centrifugate freezen protective;
E, ultrafiltration:Ultrafiltration is carried out after centrifugate is thawed, collection obtains ultrafiltrate, and ultrafiltrate cryogenic freezing is preserved;
F, sterile filling:It is filling after aseptic filtration after ultrafiltrate is thawed, in obtaining calf blood protein-removed extraction Between product, and by product in the middle of calf blood protein-removed extraction to 2~8 DEG C of preservations.
Preferably, taking in blood step, what blood collection was not taken food within being born 14 hours newly calves, and gathers environment Should be in superclean bench.The serum separated of calf blood in birth 14 hours be cell culture medium main component it One, with higher economic worth.And whole bovine blood separates the clot obtained after serum still containing higher active component, this Invention obtains calf blood protein-removed extraction intermediate from separation and Extraction in the original clot for abandoning, and on the one hand takes full advantage of little The all components of ox blood, improve its utilization rate;On the other hand also to a certain degree improve in the middle of calf blood protein-removed extraction The active component of body.
Preferably, in separating step, constant temperature places temperature control at 25~35 DEG C, and standing time is 30 minutes, centrifugation Rotating speed is 2000~4000 turns, centrifugation time 10~20 minutes, and Cord blood temperature is not less than -5 DEG C.
Preferably, milling in step, mixed using grinding mill during mixing, grinding mill rotating speed is 2000~3000 Rev/min, 50L mixed liquors of often milling need to mill 10 minutes, and the volume of the purified water of addition is 3 with the volume ratio of clot:1.
Preferably, in denaturing step, warming temperature is 80 ± 2 DEG C, holding time heating-up time is 30 minutes, and bar is centrifuged Part is 40 ± 2 DEG C, and centrifugal rotational speed is 3000~5000 revs/min, and centrifugation time is 10~20 minutes, and Cord blood temperature is not low In -5 DEG C.
Preferably, in ultrafiltration step, the membrane retention molecular weight that ultrafiltration is used is 10KD.
Preferably, in sterile filling step, pore size filter is 0.22 μm.
The beneficial effects of the present invention is:
Compared with prior art, the present invention has the advantages that:1st, the raw material blood that the present invention is gathered comes from just The bovine blood gathered within 14 hours after the birth of birth, than the active component content in the bovine blood of common process more It is high;2nd, the present invention little ox blood is progressively processed using pure physical means, so as to obtain calf blood protein-removed extraction in Mesosome, not only step is few, and the technological process of production is short, more due to using pure physical means, deproteinized calf blood being completely secured and having carried The pure property of thing intermediate is taken, the value of little ox blood is improve.
Specific embodiment:
Embodiment 1:A kind of production method of calf blood protein-removed extraction intermediate, including:
A, take blood:Whole bovine blood is gathered under cleaning ambient;
B, separation:Whole bovine blood constant temperature is placed after serum and clot natural separation into whole blood, centrifugation removes serum After obtain clot, and clot cryogenic freezing is preserved;
C, mill:The clot of freezing is thawed to normal temperature and adds purified water, mixed liquor is obtained after being well mixed;
D, denaturation:Mixed liquor is added into the denaturation that heats up in retort, less than 50 DEG C are cooled to after denaturation carries out being centrifuged again To centrifugate, by centrifugate freezen protective;
E, ultrafiltration:Ultrafiltration is carried out after centrifugate is thawed, collection obtains ultrafiltrate, and ultrafiltrate cryogenic freezing is preserved;
F, sterile filling:It is filling after aseptic filtration after ultrafiltrate is thawed, in obtaining calf blood protein-removed extraction Between product, and by product in the middle of calf blood protein-removed extraction to 2~8 DEG C of preservations.
In taking blood step, what blood collection was not taken food within being born 1 hour newly calves, and collection environment should be in ultra-clean work Make in platform.
In separating step, constant temperature places temperature control at 25 DEG C, and standing time is 30 minutes, and centrifugal rotational speed is 2000 turns, Centrifugation time 10 minutes, Cord blood temperature is not less than -5 DEG C.
Mill in step, mixed using grinding mill during mixing, grinding mill rotating speed is 2000 revs/min, and often mill 50L Mixed liquor needs to mill 10 minutes, and the volume of the purified water of addition is 3 with the volume ratio of clot:1.
In denaturing step, warming temperature is 80 ± 2 DEG C, and holding time heating-up time is 30 minutes, and centrifugal condition is 40 ± 2 DEG C, centrifugal rotational speed is 3000 revs/min, and centrifugation time is 10~20 minutes, and Cord blood temperature is not less than -5 DEG C.
In ultrafiltration step, the membrane retention molecular weight that ultrafiltration is used is 10KD.
In sterile filling step, pore size filter is 0.22 μm.
The correlated traits detection of table 1, the calf blood protein-removed extraction of the production of embodiment 1
Embodiment 2:A kind of production method of calf blood protein-removed extraction intermediate, including:
A, take blood:Whole bovine blood is gathered under cleaning ambient;
B, separation:Whole bovine blood constant temperature is placed after serum and clot natural separation into whole blood, centrifugation removes serum After obtain clot, and clot cryogenic freezing is preserved;
C, mill:The clot of freezing is thawed to normal temperature and adds purified water, mixed liquor is obtained after being well mixed;
D, denaturation:Mixed liquor is added into the denaturation that heats up in retort, less than 50 DEG C are cooled to after denaturation carries out being centrifuged again To centrifugate, by centrifugate freezen protective;
E, ultrafiltration:Ultrafiltration is carried out after centrifugate is thawed, collection obtains ultrafiltrate, and ultrafiltrate cryogenic freezing is preserved;
F, sterile filling:It is filling after aseptic filtration after ultrafiltrate is thawed, in obtaining calf blood protein-removed extraction Between product, and by product in the middle of calf blood protein-removed extraction to 2~8 DEG C of preservations.
In taking blood step, what blood collection was not taken food for 2 hours from being born newly calves, and collection environment should be in superclean bench It is interior.
In separating step, constant temperature places temperature control at 35 DEG C, and standing time is 30 minutes, and centrifugal rotational speed is 4000 turns, Centrifugation time 20 minutes, Cord blood temperature is not less than -5 DEG C.
Mill in step, mixed using grinding mill during mixing, grinding mill rotating speed is 3000 revs/min, and often mill 50L Mixed liquor needs to mill 10 minutes, and the volume of the purified water of addition is 3 with the volume ratio of clot:1.
In denaturing step, warming temperature is 80 ± 2 DEG C, and holding time heating-up time is 30 minutes, and centrifugal condition is 40 ± 2 DEG C, centrifugal rotational speed is 5000 revs/min, and centrifugation time is 10~20 minutes, and Cord blood temperature is not less than -5 DEG C.
In ultrafiltration step, the membrane retention molecular weight that ultrafiltration is used is 10KD.
In sterile filling step, pore size filter is 0.22 μm.
The correlated traits detection of table 2, the calf blood protein-removed extraction of the production of embodiment 2
Embodiment 3:A kind of production method of calf blood protein-removed extraction intermediate, including:
A, take blood:Whole bovine blood is gathered under cleaning ambient;
B, separation:Whole bovine blood constant temperature is placed after serum and clot natural separation into whole blood, centrifugation removes serum After obtain clot, and clot cryogenic freezing is preserved;
C, mill:The clot of freezing is thawed to normal temperature and adds purified water, mixed liquor is obtained after being well mixed;
D, denaturation:Mixed liquor is added into the denaturation that heats up in retort, less than 50 DEG C are cooled to after denaturation carries out being centrifuged again To centrifugate, by centrifugate freezen protective;
E, ultrafiltration:Ultrafiltration is carried out after centrifugate is thawed, collection obtains ultrafiltrate, and ultrafiltrate cryogenic freezing is preserved;
F, sterile filling:It is filling after aseptic filtration after ultrafiltrate is thawed, in obtaining calf blood protein-removed extraction Between product, and by product in the middle of calf blood protein-removed extraction to 2~8 DEG C of preservations.
In taking blood step, what blood collection was not taken food for 14 hours from being born newly calves, and collection environment should be in ultra-clean work In platform.
In separating step, constant temperature places temperature control at 30 DEG C, and standing time is 30 minutes, and centrifugal rotational speed is 3000 turns, Centrifugation time 15 minutes, Cord blood temperature is not less than -5 DEG C.
Mill in step, mixed using grinding mill during mixing, grinding mill rotating speed is 2500 revs/min, and often mill 50L Mixed liquor needs to mill 10 minutes, and the volume of the purified water of addition is 3 with the volume ratio of clot:1.
In denaturing step, warming temperature is 80 ± 2 DEG C, and holding time heating-up time is 30 minutes, and centrifugal condition is 40 ± 2 DEG C, centrifugal rotational speed is 4000 revs/min, and centrifugation time is 15 minutes, and Cord blood temperature is not less than -5 DEG C.
In ultrafiltration step, the membrane retention molecular weight that ultrafiltration is used is 10KD.
In sterile filling step, pore size filter is 0.22 μm.
The correlated traits detection of table 3, the calf blood protein-removed extraction of the production of embodiment 3
Presently preferred embodiments of the present invention is the foregoing is only, those of ordinary skill in the art are not making creative work Under the premise of the every other embodiment that obtained, should all belong to the scope of protection of the invention.

Claims (7)

1. a kind of production method of calf blood protein-removed extraction intermediate, it is characterised in that:Including:
A, take blood:Whole bovine blood is gathered under cleaning ambient;
B, separation:Whole bovine blood constant temperature is placed after serum and clot natural separation into whole blood, centrifugation removed and obtained after serum To clot, and clot cryogenic freezing is preserved;
C, mill:The clot of freezing is thawed to normal temperature and adds purified water, mixed liquor is obtained after being well mixed;
D, denaturation:Mixed liquor is added and is heated up denaturation in retort, be cooled to after denaturation less than 50 DEG C carry out again centrifugation obtain from Heart liquid, by centrifugate freezen protective;
E, ultrafiltration:Ultrafiltration is carried out after centrifugate is thawed, collection obtains ultrafiltrate, and ultrafiltrate cryogenic freezing is preserved;
F, sterile filling:It is filling after aseptic filtration after ultrafiltrate is thawed, obtain in the middle of calf blood protein-removed extraction Product, and by product in the middle of calf blood protein-removed extraction to 2~8 DEG C of preservations.
2. as described in claim 1 a kind of production method of calf blood protein-removed extraction intermediate, it is characterised in that:Institute State and take in blood step, what blood collection was not taken food within being born 14 hours newly calves, collection environment should be in superclean bench It is interior.
3. as described in claim 1 a kind of production method of calf blood protein-removed extraction intermediate, it is characterised in that:Institute In stating separating step, constant temperature places temperature control at 25~35 DEG C, and standing time is 30 minutes, and centrifugal rotational speed is 2000~4000 Turn, centrifugation time 10~20 minutes, Cord blood temperature is not less than -5 DEG C.
4. as described in claim 1 a kind of production method of calf blood protein-removed extraction intermediate, it is characterised in that:Institute State and mill in step, mixed using grinding mill during mixing, grinding mill rotating speed is 2000~3000 revs/min, and often mill 50L Mixed liquor needs to mill 10 minutes, and the volume of the purified water of addition is 3 with the volume ratio of clot:1.
5. as described in claim 2 a kind of production method of calf blood protein-removed extraction intermediate, it is characterised in that:Institute In stating denaturing step, warming temperature is 80 ± 2 DEG C, and holding time heating-up time is 30 minutes, and centrifugal condition is 40 ± 2 DEG C, from Heart rotating speed is 3000~5000 revs/min, and centrifugation time is 10~20 minutes, and Cord blood temperature is not less than -5 DEG C.
6. a kind of production method of calf blood protein-removed extraction intermediate as described in claim 1, is characterized in that:It is described In ultrafiltration step, the membrane retention molecular weight that ultrafiltration is used is 10KD.
7. a kind of production method of calf blood protein-removed extraction intermediate as described in claim 1, is characterized in that:It is described In sterile filling step, pore size filter is 0.22 μm.
CN201611176125.5A 2016-12-19 2016-12-19 Production method of deproteinized calf blood extractive intermediates Pending CN106619717A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611176125.5A CN106619717A (en) 2016-12-19 2016-12-19 Production method of deproteinized calf blood extractive intermediates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611176125.5A CN106619717A (en) 2016-12-19 2016-12-19 Production method of deproteinized calf blood extractive intermediates

Publications (1)

Publication Number Publication Date
CN106619717A true CN106619717A (en) 2017-05-10

Family

ID=58823063

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611176125.5A Pending CN106619717A (en) 2016-12-19 2016-12-19 Production method of deproteinized calf blood extractive intermediates

Country Status (1)

Country Link
CN (1) CN106619717A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110812442A (en) * 2019-12-06 2020-02-21 湖北威仕生物药业股份有限公司 Preparation method and application of five-ginseng-astragalus oral solution

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1586499A (en) * 2004-07-08 2005-03-02 合肥兆峰科大药业有限公司 Calf blood deproteinizing extract, its eye ointment preparation and its preparing method
CN101049318A (en) * 2006-04-06 2007-10-10 武汉人福药业有限责任公司 New method for preparing extractive of calf blood with protein being removed
CN101084922A (en) * 2007-06-26 2007-12-12 黑龙江省珍宝岛制药有限公司 Process for preparing calf blood protein-removed extraction injection
CN101433553A (en) * 2007-12-07 2009-05-20 吉林康乃尔药业有限公司 Method for preparing deproteinized extract of calf blood and freeze-dried powder thereof
CN101690759A (en) * 2009-10-28 2010-04-07 吉林省长春皓月清真肉业股份有限公司 Health product for improving nutritional anemia and preparation method thereof
CN101697977A (en) * 2009-11-26 2010-04-28 罗诚 Deproteinized calf blood extractive injection and preparation method thereof
CN101947242A (en) * 2010-09-26 2011-01-19 武汉华龙生物制药有限公司 Preparation method of deproteinized calf blood extract
CN102908363A (en) * 2012-11-05 2013-02-06 北华大学 Deproteinized calf blood extract and preparation process thereof
CN103191151A (en) * 2013-04-02 2013-07-10 黑龙江迪龙制药有限公司 Method for preparing calf-blood deproteinized extract

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1586499A (en) * 2004-07-08 2005-03-02 合肥兆峰科大药业有限公司 Calf blood deproteinizing extract, its eye ointment preparation and its preparing method
CN101049318A (en) * 2006-04-06 2007-10-10 武汉人福药业有限责任公司 New method for preparing extractive of calf blood with protein being removed
CN101084922A (en) * 2007-06-26 2007-12-12 黑龙江省珍宝岛制药有限公司 Process for preparing calf blood protein-removed extraction injection
CN101433553A (en) * 2007-12-07 2009-05-20 吉林康乃尔药业有限公司 Method for preparing deproteinized extract of calf blood and freeze-dried powder thereof
CN101690759A (en) * 2009-10-28 2010-04-07 吉林省长春皓月清真肉业股份有限公司 Health product for improving nutritional anemia and preparation method thereof
CN101697977A (en) * 2009-11-26 2010-04-28 罗诚 Deproteinized calf blood extractive injection and preparation method thereof
CN101947242A (en) * 2010-09-26 2011-01-19 武汉华龙生物制药有限公司 Preparation method of deproteinized calf blood extract
CN102908363A (en) * 2012-11-05 2013-02-06 北华大学 Deproteinized calf blood extract and preparation process thereof
CN103191151A (en) * 2013-04-02 2013-07-10 黑龙江迪龙制药有限公司 Method for preparing calf-blood deproteinized extract

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
刘超锋 等: "国内纳滤膜在动植物活性成分提取中应用的技术进展", 《林业实用技术》 *
宋春奎 等: "新生牛血清制备法的改进", 《军事医学科学院院刊》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110812442A (en) * 2019-12-06 2020-02-21 湖北威仕生物药业股份有限公司 Preparation method and application of five-ginseng-astragalus oral solution
CN110812442B (en) * 2019-12-06 2022-02-08 湖北威仕生物药业股份有限公司 Preparation method and application of five-ginseng-astragalus oral solution

Similar Documents

Publication Publication Date Title
CN106333193B (en) Full-resource utilization method of sweet potato starch processing wastewater
CN108070629A (en) A kind of method of the numb albumen oligopeptide of industrialized production fire
CN105054067B (en) A kind of preparation method of water-soluble moringa oleifera leaf extractive
CN107446978A (en) A kind of stem of noble dendrobium small-molecular peptides and preparation method thereof
CN104961823A (en) Purification method applicable to manufacturing food-grade ovalbumin on large scale
CN105167064A (en) Method of processing clear wolfberry juice by comprehensive utilization of wolfberry residues
CN104798902A (en) Utilization method of yellow thick liquid obtained after preparation of bean curd through functional coagulator
CN107523602A (en) A kind of extracting method of black-bone chicken active peptide
CN104877007B (en) Yak milk lactalbumin source ACE inhibitor peptides and preparation method thereof
CN108815300A (en) A kind of preparation method of wolfberry fruit extract
CN106901116B (en) A kind of fermentation process of Amorphophallus rivieri beverage
CN106619717A (en) Production method of deproteinized calf blood extractive intermediates
CN205409475U (en) Solid sugarcane juice processingequipment is strained to multistage mixed membrane
CN111034885A (en) Bird's nest elastin peptide plant beverage and preparation method thereof
CN107048417A (en) A kind of preparation method of the peach kernel polypeptide oral liquor of high bioavilability
RU2409966C1 (en) Method for production of girasol plant milk extract
KR101283323B1 (en) Production method of ginseng steamed red concentrated solution
CN102273517A (en) Trichosanthes kirilowii Maxim seed plant protein beverage and production method thereof
CN106720801B (en) Burdock tea rich in inulin
CN102652556B (en) Preparation method of instant kudzuvine root particles
CN114939084A (en) Russule extract and preparation method and application thereof
CN107893095A (en) A kind of method that marine source albumen prepares high F value oligopeptide
CN107212324B (en) Method for preparing reconstituted pomelo fruit powder from degraded pomelo juice
CN104082410B (en) A kind of downy grape collagen polypeptide Ca Yoghourt
CN113995141A (en) Squid-derived active peptide absorbable jelly and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170510